Harriet De Wit, Ph.D., professor of psychiatry and behavioral neuroscience at the University of Chicago (@UChicago), discusses “Microdosing: Fact or Fiction.” The lecture was recorded March 23, 2023, at the Psychedelic Summit on the UC Davis Health campus in Sacramento, California.

The UC Davis Psychedelic Summit brought together national experts to explore what the rapidly evolving field of psychedelics and neurotherapeutics may mean for neuropsychiatric and neurodegenerative diseases. These new treatment types may hold promise for anxiety, depression, substance use, obsessive-compulsive and post-traumatic stress disorders, among others. The event was hosted by the UC Davis Department of Psychiatry and Behavioral Sciences, the UC Davis Institute for Psychedelics and Neurotherapeutics, and the UC Davis Behavioral Health Center for Excellence.

Watch more lectures from this conference: [ Ссылка ]
Learn more about the Psychedelic Summit at UC Davis: [ Ссылка ]
UC Davis Department of Psychiatry and Behavioral Sciences: [ Ссылка ]
UC Davis Institute for Psychedelics and Neurotherapeutics: [ Ссылка ]
UC Davis Behavioral Health Center for Excellence: [ Ссылка ]
See the latest news from UC Davis Health: [ Ссылка ]

0:00 Introduction
0:26 Psychedelic drugs and depression
2:29 Microdosing LSD explained
9:14 LSD in animal models
10:18 Human studies with low doses of LSD
17:02 Study 1 - Behavioral dose determination
24:26 Study 2 - Effect of LSD on functional connectivity fMRI
25:23 Study 3 - Effects on EEG
28:39 Study 4 - Repeated microcode study
36:13 Latest study - LSD in participants with high vs. low depression scores
38:48 Remaining questions after studies
41:40 Questions from the audience

The information in this video was accurate as of the upload date, 5/11/23. For information purposes only. Consult your local medical authority for advice.

#microdosing #psychedelics #lsd #ucdavis

свернуть